Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease | MicrobiomeTrials← Back to trialsNCT06144970
Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2027-01-19Est. Completion: 2028-07-28
Enrollment target: 24 participants Other microbiome trials you might be interested in
Degenerative Disc DiseaseDDDDegenerative Disc Disease LumbarDegenerative Disc Disease, LumbarLumbar Disc HerniationDisc Herniation, LumbarBone Marrow Aspirate ConcentrateIntervertebral Disc DisplacementLow Back PainChronic Low Back Pain (CLBP)CLBP - Chronic Low Back Pain
The goal of this clinical trial is to find out whether adding a bone-marrow aspirate concentrate (BMAC) injection during…
Manhattan, United StatesEst. completion Jan 2030
Completed
The pathophysiology arises from structural and biochemical degeneration within the intervertebral disc rather than direc…
Islamabad, PakistanCompleted Jun 8, 2026
Cervical Disc Degenerative DisorderCervical Fusion
The goal of this observational post-market study is to evaluate the clinical performance and safety of the ITC CERVICAL …
Misterbianco, ItalyCompleted Jul 24, 2026